FDA To Issue Five Guidances On Adaptive Clinical Trial Design – Gottlieb
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA’s first guidance document on adaptive clinical trial designs will discuss the use of multiple endpoints in the same trial, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb said July 10.